Contrast-enhanced ultrasonography in Crohn's disease.

Area of Science:

• Gastroenterology
• Medical Imaging
• Diagnostic Ultrasound

Background:

• Ileal Crohn's disease requires accurate assessment of disease activity for effective management.
• Conventional ultrasound with color power Doppler (CPD) has limitations in defining disease severity.
• Contrast-enhanced power Doppler (CEPD) ultrasound offers potential for improved diagnostic accuracy.

Purpose of the Study:

• To evaluate the diagnostic efficacy of CEPD compared to CPD in assessing ileal Crohn's disease activity.
• To determine the utility of CEPD in acute phases and during treatment follow-up.
• To assess the correlation of CEPD findings with clinical and laboratory markers of disease activity.

Main Methods:

• A study involving 15 patients with ileal Crohn's disease.
• Ultrasound examinations included standard CPD and CEPD with a contrast agent (SonoVue).
• Disease activity was assessed using the Crohn's Disease Activity Index (CDAI) and biohumoural markers.

Main Results:

• CEPD demonstrated higher reliability than US-CPD in diagnosing Crohn's disease.
• CEPD findings showed significant statistical agreement with clinical and laboratory indices of disease activity.
• The semiquantitative scoring system effectively assessed bowel wall enhancement.

Conclusions:

• US-CPD is crucial for monitoring Crohn's disease patients.
• Systematic use of US contrast agents enhances diagnostic performance in abdominal ultrasound.
• CEPD provides valuable information for improved treatment planning and efficacy monitoring in Crohn's disease.